Morphologic and phenotypic changes of human neuroblastoma cells in culture induced by cytosine arabinoside

M. Ponzoni, M. Lanciotti, A. Melodia, A. Casalaro, P. Cornaglia-Ferraris

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

The effects of cytosine-arabinoside (ARA-C) on the growth and phenotypic expression of a new human neuroblastoma (NB) cell line (GI-ME-N) have been extensively tested. Low doses of ARA-C allowing more than 90% cell viability induce morphological differentiation and growth inhibition. Differentiated cells were larger and flattened with elongated dendritic processes; such cells appeared within 48 h after a dose of ARA-C as low as 0.1 μ/ml (about 1000-fold lower than the conventional clinic dose). The new morphological aspect reached the maximum expression after 5-6 days of culture being independent from the addition of extra drug to the culture. A decrease in [3H]thymidine incorporation was also observed within 24 h and the cell growth was completely inhibited on the sixth day. Moreover, ARA-C strongly inhibited anchorage-independent growth in soft agar assay. Membrane immunofluorescence showed several dramatic changes in NB-specific antigen expression after 5 days of treatment with ARA-C. At the same time ARA-C also modulated cytoskeletal proteins and slightly increased catecholamine expression. These findings suggest that noncytotoxic doses of ARA-C do promote the differentiation of GI-ME-N neuroblastoma cells associated with reduced expression of the malignant phenotype.

Original languageEnglish
Pages (from-to)226-237
Number of pages12
JournalExperimental Cell Research
Volume181
Issue number1
DOIs
Publication statusPublished - 1989

Fingerprint

Cytarabine
Neuroblastoma
Cell Culture Techniques
Growth
Cytoskeletal Proteins
Thymidine
Agar
Catecholamines
Fluorescent Antibody Technique
Cell Survival
Phenotype
Antigens
Cell Line
Membranes
Pharmaceutical Preparations
Therapeutics

ASJC Scopus subject areas

  • Cell Biology

Cite this

Morphologic and phenotypic changes of human neuroblastoma cells in culture induced by cytosine arabinoside. / Ponzoni, M.; Lanciotti, M.; Melodia, A.; Casalaro, A.; Cornaglia-Ferraris, P.

In: Experimental Cell Research, Vol. 181, No. 1, 1989, p. 226-237.

Research output: Contribution to journalArticle

@article{1635bd990d564b9b9d8600ce12e15057,
title = "Morphologic and phenotypic changes of human neuroblastoma cells in culture induced by cytosine arabinoside",
abstract = "The effects of cytosine-arabinoside (ARA-C) on the growth and phenotypic expression of a new human neuroblastoma (NB) cell line (GI-ME-N) have been extensively tested. Low doses of ARA-C allowing more than 90{\%} cell viability induce morphological differentiation and growth inhibition. Differentiated cells were larger and flattened with elongated dendritic processes; such cells appeared within 48 h after a dose of ARA-C as low as 0.1 μ/ml (about 1000-fold lower than the conventional clinic dose). The new morphological aspect reached the maximum expression after 5-6 days of culture being independent from the addition of extra drug to the culture. A decrease in [3H]thymidine incorporation was also observed within 24 h and the cell growth was completely inhibited on the sixth day. Moreover, ARA-C strongly inhibited anchorage-independent growth in soft agar assay. Membrane immunofluorescence showed several dramatic changes in NB-specific antigen expression after 5 days of treatment with ARA-C. At the same time ARA-C also modulated cytoskeletal proteins and slightly increased catecholamine expression. These findings suggest that noncytotoxic doses of ARA-C do promote the differentiation of GI-ME-N neuroblastoma cells associated with reduced expression of the malignant phenotype.",
author = "M. Ponzoni and M. Lanciotti and A. Melodia and A. Casalaro and P. Cornaglia-Ferraris",
year = "1989",
doi = "10.1016/0014-4827(89)90196-1",
language = "English",
volume = "181",
pages = "226--237",
journal = "Experimental Cell Research",
issn = "0014-4827",
publisher = "Academic Press Inc.",
number = "1",

}

TY - JOUR

T1 - Morphologic and phenotypic changes of human neuroblastoma cells in culture induced by cytosine arabinoside

AU - Ponzoni, M.

AU - Lanciotti, M.

AU - Melodia, A.

AU - Casalaro, A.

AU - Cornaglia-Ferraris, P.

PY - 1989

Y1 - 1989

N2 - The effects of cytosine-arabinoside (ARA-C) on the growth and phenotypic expression of a new human neuroblastoma (NB) cell line (GI-ME-N) have been extensively tested. Low doses of ARA-C allowing more than 90% cell viability induce morphological differentiation and growth inhibition. Differentiated cells were larger and flattened with elongated dendritic processes; such cells appeared within 48 h after a dose of ARA-C as low as 0.1 μ/ml (about 1000-fold lower than the conventional clinic dose). The new morphological aspect reached the maximum expression after 5-6 days of culture being independent from the addition of extra drug to the culture. A decrease in [3H]thymidine incorporation was also observed within 24 h and the cell growth was completely inhibited on the sixth day. Moreover, ARA-C strongly inhibited anchorage-independent growth in soft agar assay. Membrane immunofluorescence showed several dramatic changes in NB-specific antigen expression after 5 days of treatment with ARA-C. At the same time ARA-C also modulated cytoskeletal proteins and slightly increased catecholamine expression. These findings suggest that noncytotoxic doses of ARA-C do promote the differentiation of GI-ME-N neuroblastoma cells associated with reduced expression of the malignant phenotype.

AB - The effects of cytosine-arabinoside (ARA-C) on the growth and phenotypic expression of a new human neuroblastoma (NB) cell line (GI-ME-N) have been extensively tested. Low doses of ARA-C allowing more than 90% cell viability induce morphological differentiation and growth inhibition. Differentiated cells were larger and flattened with elongated dendritic processes; such cells appeared within 48 h after a dose of ARA-C as low as 0.1 μ/ml (about 1000-fold lower than the conventional clinic dose). The new morphological aspect reached the maximum expression after 5-6 days of culture being independent from the addition of extra drug to the culture. A decrease in [3H]thymidine incorporation was also observed within 24 h and the cell growth was completely inhibited on the sixth day. Moreover, ARA-C strongly inhibited anchorage-independent growth in soft agar assay. Membrane immunofluorescence showed several dramatic changes in NB-specific antigen expression after 5 days of treatment with ARA-C. At the same time ARA-C also modulated cytoskeletal proteins and slightly increased catecholamine expression. These findings suggest that noncytotoxic doses of ARA-C do promote the differentiation of GI-ME-N neuroblastoma cells associated with reduced expression of the malignant phenotype.

UR - http://www.scopus.com/inward/record.url?scp=0024510045&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024510045&partnerID=8YFLogxK

U2 - 10.1016/0014-4827(89)90196-1

DO - 10.1016/0014-4827(89)90196-1

M3 - Article

C2 - 2917605

AN - SCOPUS:0024510045

VL - 181

SP - 226

EP - 237

JO - Experimental Cell Research

JF - Experimental Cell Research

SN - 0014-4827

IS - 1

ER -